Parsons Capital Management Incri buys $8,511,948 stake in CVS Health Corp (CVS)

CVS Health Corp (CVS) : Parsons Capital Management Incri scooped up 3,013 additional shares in CVS Health Corp during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Apr 26, 2016. The investment management firm now holds a total of 84,696 shares of CVS Health Corp which is valued at $8,511,948.CVS Health Corp makes up approximately 1.16% of Parsons Capital Management Incri’s portfolio.

CVS Health Corp opened for trading at $100.5 and hit $101.93 on the upside on Monday, eventually ending the session at $101.45, with a gain of 0.95% or 0.95 points. The heightened volatility saw the trading volume jump to 54,86,259 shares. Company has a market cap of $111,442 M.

Other Hedge Funds, Including , K.j. Harrison Partners Inc boosted its stake in CVS in the latest quarter, The investment management firm added 12,250 additional shares and now holds a total of 31,425 shares of CVS Health Corp which is valued at $3,158,213. CVS Health Corp makes up approx 1.65% of K.j. Harrison Partners Inc’s portfolio.Advisory Services Network boosted its stake in CVS in the latest quarter, The investment management firm added 2,448 additional shares and now holds a total of 10,087 shares of CVS Health Corp which is valued at $1,023,225. CVS Health Corp makes up approx 0.27% of Advisory Services Network’s portfolio.Appleton Partners Incma boosted its stake in CVS in the latest quarter, The investment management firm added 64,389 additional shares and now holds a total of 90,238 shares of CVS Health Corp which is valued at $9,153,743. CVS Health Corp makes up approx 1.78% of Appleton Partners Incma’s portfolio.Oakbrook Investments boosted its stake in CVS in the latest quarter, The investment management firm added 42,925 additional shares and now holds a total of 63,546 shares of CVS Health Corp which is valued at $6,496,943. CVS Health Corp makes up approx 0.41% of Oakbrook Investments’s portfolio.

On the company’s financial health, CVS Health Corp reported $1.18 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on May 3, 2016. Analyst had a consensus of $1.16. The company had revenue of $43215.00 million for the quarter, compared to analysts expectations of $43000.77 million. The company’s revenue was up 18.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.14 EPS.

Many Wall Street Analysts have commented on CVS Health Corp. Company shares were Reiterated by Barclays on Mar 10, 2016 to “Overweight”, Firm has raised the Price Target to $ 115 from a previous price target of $110 .Shares were Reiterated by Mizuho on Feb 10, 2016 to “Buy” and Lowered the Price Target to $ 104 from a previous price target of $113 .CVS Health Corp was Initiated by Atlantic Equities to “Overweight” on Feb 3, 2016.

CVS Health Corporation together with its subsidiaries is a pharmacy company. The Company operates through three business segments: Pharmacy Services Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services Novologix and Navarro Health Services names. The Retail Pharmacy segment sells prescription drugs and an assortment of general merchandise including over-the-counter drugs beauty products and cosmetics personal care products convenience foods photo finishing seasonal merchandise and greeting cards through the Company’s retail stores online retail pharmacy Websites and retail healthcare clinics. The Corporate segment provides management and administrative services to support the overall operations of the Company. The Company through its wholly owned subsidiary Omnicare Inc. provides pharmacy services to long term care facilities.

Leave a Reply

CVS Health Corp - Is it time to Sell?

Top Brokerage Firms are advising their investors on CVS Health Corp. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.